ReviewJournal of ginseng research2026
The role of ginseng and ginsenosides in ROS and cardiovascular disease.
Review in Journal of ginseng research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- Gintonin protects hematopoietic stem cells and accelerates bone marrow recovery following cyclophosphamide-induced injury.Journal of ginseng research · 2026Article
- Emerging and underexplored ginsenosides in cancer therapy (2020-2025): Beyond cytotoxic mechanisms.Journal of ginseng research · 2026Review
- The roles of ginseng and ginsenosides for immune regulation: Relation to immunometabolic responses.Journal of ginseng research · 2026Review
- Protective effects of ginseng against reproductive injury: mechanisms and research progress.Naunyn-Schmiedeberg's archives of pharmacology · 2026Review
- Interfacial and Molecular Mechanisms of Pancreatic Lipase Modulation by Saponin-Rich Extracts with Antioxidant Activity.Molecules (Basel, Switzerland) · 2026Article
- Review
- Panax japonicus and Dioscorea deltoidea Cell Cultures as a Source of Stable Antioxidant Food Components.Plant foods for human nutrition (Dordrecht, Netherlands) · 2026Article
- Notoginsenoside R1 Inhibits Porcine Deltacoronavirus Infection In Vitro by Restoring SERCA2-Mediated Calcium Homeostasis.Animals : an open access journal from MDPI · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
An imbalance in reactive oxygen species (ROS) can lead to severe tissue damage and ultimately result in cell death. While ROS plays a crucial role in cellular signaling, excessive ROS production disrupts intracellular homeostasis, causing oxidative stress, which is a contributing factor to cardiac diseases. Ginseng and its ginsenosides have demonstrated potent antioxidant and cardioprotective properties, and their effectiveness in combating oxidative stress which is closely associated with cardiac health has been thoroughly documented. This review summarizes the cardioprotective roles and molecular mechanisms through which ginseng and its key and rare ginsenosides regulate excess ROS production, restore antioxidant enzyme function, and ameliorate cardiac damage. Key ginsenosides such as Rg1, Rg3, Rb1, and notoginsenoside R1, along with rare forms like Rh1, Rh4, F
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.